1,3-diaryl substituted ureas as modulators of kinase activity

Details for Australian Patent Application No. 2006204790 (hide)

Owner CGI Pharmaceuticals, Inc.

Inventors Pippin, Douglas A. I.; Blomgren, Peter A.; Mitchell, Scott A.; Danca, Mihaela Diana; Brittelli, David R.; Desimone, Robert W.

Agent Davies Collison Cave

Pub. Number AU-B-2006204790

PCT Pub. Number WO2006/076593

Priority 60/732,999 02.11.05 US; 60/643,886 14.01.05 US

Filing date 13 January 2006

Wipo publication date 20 July 2006

Acceptance publication date 23 August 2012

International Classifications

C07D 401/06 Heterocyclic compounds containing two or more hetero rings

A61K 31/404

A61P 35/04 Antineoplastic agents

Event Publications

2 August 2007 PCT application entered the National Phase

  PCT publication WO2006/076593 Priority application(s): WO2006/076593

23 August 2012 Application Accepted

  Published as AU-B-2006204790

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006204791-Antibodies and Fc fusion proteins with altered immunogenicity

2006204787-Perfusion and/or preservation solution for organs